论文部分内容阅读
GlaxoSmithkline公司和Aradigm公司采用AERx技术平台合作开发的AERx止痛系统（AERxmPMS）,是通过吸入装置吸入吗啡,用于缓解癌性突发痛,AERx止痛系统Ⅰ期临床研究结果显示,AERx起效速度类似目前作为金本位（goidstandard）的静脉注射。
AERx Analgesia System (AERxmPMS) developed by GlaxoSmithKline and Aradigm using the AERx Technology Platform is a form of inhalation of morphine to relieve cancerous sudden pain. AERx Analgesia Phase I clinical studies have shown that AERx has a similar onset of action Currently administered as a goidstandard intravenous injection.